Improved Serodiagnostic Testing for Lyme Disease: Results of a Multicenter Serologic Evaluation

Emerging Infectious Diseases

Volumn 2, Issue 2, 1996, Pages 136-140

  Craven, Robert B ^a   Quan, Thomas J ^a   Bailey, Raymond E ^a   Dattwyler, Raymond ^b   Ryan, Raymond W ^c   Sigal, Leonard H ^d   Steere, Allen C ^e   Sullivan, Bradley ^f   Johnson, Barbara J B ^a   Dennis, David T ^a   Gubler, Duane J ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^d ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f MARSHFIELD CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY;

ARTICLE; BLOOD; BORRELIA BURGDORFERI; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LYME DISEASE; METHODOLOGY; MICROBIOLOGY; MULTICENTER STUDY; SENSITIVITY AND SPECIFICITY; SEROLOGY; WESTERN BLOTTING;

ANTIBODIES, BACTERIAL; BLOTTING, WESTERN; BORRELIA BURGDORFERI GROUP; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LYME DISEASE; MULTICENTER STUDIES; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 0030114856     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid0202.960211     Document Type: Article

References (24)

1. Steere, AC. Lyme disease. N Engl J Med 1989;321:586-96.
2. Logigian EL, Kaplan RF, Steere AC. Chronic neurologic manifestations of Lyme disease. N Engl J Med 1990;323:1438-44.
3. Steere AC, Bartenhagen NH, Craft JE, et al. The early clinical manifestations of Lyme disease. Ann Intern Med 1989;99:76-82.
4. Bakken LL, Case KL, Callister SM, Bourdeau NJ, Schell RF. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. JAMA 1992;268:891-5.
5. Hedberg CW, Osterholm MT, MacDonald KL, White KE. An interlaboratory study of antibody to Borrelia burgdorferi. J Infect Dis 1987;155:1325-7.
6. Hedberg CW, Osterholm MT. Serologic tests for antibody to Borrelia burgdorferi - another Pandora's box for medicine? Arch Intern Med 1990;150:732-3.
7. Jones JM. Serodiagnosis of Lyme disease. Ann Intern Med 1991;114:1064.
8. Lane RS, Lennette ET, Madigan JE. Interlaboratory and intralaboratory comparisons of indirect immunofluorescence assays for serodiagnosis of Lyme disease. J Clin Microbiol 1990;28:1774-9.
9. Luger SW, Krauss E. Serologic tests for Lyme disease: interlaboratory variability. Arch Intern Med 1990;15:761-3.
10. Schwartz BS, Goldstein MD, Ribeiro JMC, Schulze TL, Shahied SI. Antibody testing in Lyme disease: a comparison of results in four laboratories. JAMA 1989;262:3431-4.
11. Quan TJ, Wilmoth BA, Carter LG, Bailey RE. A comparison of some commercially available serodiagnostic kits for Lyme disease. In: Proceedings of the First National Conference on Lyme Disease Testing (Dearborn, Michigan). Washington, DC: Association of State and Territorial Public Health Laboratory Directors, 1991:61-73.
12. Steere AC, Grodzicki RL, Kornblatt AN, et al. The spirochetal etiology of Lyme disease. N Engl J Med 1983;308:733-40.
13. Benach JL, Bosler EM, Hanrahan JP, et al. Spirochetes isolated from the blood of two patients with Lyme disease. N Engl J Med 1983;308:740-2.
14. Berger BW, Johnson RC, Kodner C, Coleman L. Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin. J Clin Microbiol 1992;30:359-61.
15. Centers for Disease Control and Prevention. Case definitions for public health surveillance. MMWR 1990;39(RR-13):19-21.
16. Russell H, Sampson JS, Schmid GP, Wilkinson HW, Plikaytis B. Enzyme-linked immunosorbent assay and indirect immun ofluorescence assay for Lyme disease. J Infect Dis 1984;149:465-70.
17. Hansen K, Åsbrink E. Serodiagnosis of erythema migrans and acrodermatitis chronica atrophicans by the Borrelia burgdorferi flagellum enzyme-linked immunosorbent assay. J Clin Micrbiol 1989;27:545-51.
18. Craft JE, Grodzicki RL, Steere AC. Antibody response in Lyme disease: evaluation of tests. J Infect Dis 1984;149:789-95.
19. Grodzicki RL, Steere AC. Comparison of immunoblotting and indirect enzyme-linked immunosorbent assay using different antigen preparations for diagnosing early Lyme disease. J Infect Dis 1988;157:790-97.
20. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993;167:392-400.
21. Fister RD, Weymouth LA, McLaughlin JC, Ryan RW, Tilton RC. Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum. J Clin Microbiol 1989;27:2834-37.
22. Dattwyler RJ, Volkman DJ, Luft BJ, Halperin JJ, Thomas J, Golightly MG. Seronegative Lyme disease: dissociation of specific T- and B-lymphocytic response to Borrelia burgdorferi. N Engl J Med 1988;319:1441-6.
23. Association of State and Territorial Public Health Laboratory Directors and the Centers for Disease Control and Prevention. Recommendations. In: Proceedings of the Second National Conference on Serologic Diagnosis of Lyme Disease (Dearborn, Michigan). Washington, DC: Association of State and Territorial Public Health Laboratory Directors 1995:1-5.
24. Johnson BJB, Robbins KE, Bailey RE, et al. Serodiagnosis of Lyme disease: accuracy of a two-step approach using a flagella-based ELISA and immunoblotting. J Infect Dis 1995; submitted.